Trial Profile
A retrospective, observational study asseessing the efficacy and safety of salvage therapy using carlzomib for relapsed or refractory multiple myeloma patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2016 New trial record